Keystone Nano’s flagship development is the NanoJacket (TM). The Penn State University-patented technology enables creation of stable, non-toxic, 5 to 50 nm-composite particles to deliver drugs and/or fluorescent molecules. The technology was developed through collaborative efforts between Professor James Adairs research group in Penn States Materials Research Institute and Passanati Distinguished Professor Mark Kesters research group at the Hershey Medical Center. Adair and Kester are principles in Keystone Nano. The firm’s technology, which could be applied in cancer treatment as well as other biomedical applications, was recently featured in ACS Nano, a peer-reviewed publication.
The firm will continue to be headquartered in Boalsburg, but Davidson says the lab space in Hershey makes sense. “We already work closely with the doctors at Hershey Medical Center with different kinds of experiments. We’ll be doing some preliminary product testing, looking at pharmaceutical properties” with technologies available at the Center.
Separately, Keystone Nano maintains a partnership with Nalco Company, a leading global provider of integrated water treatment services, chemicals and equipment. Their joint venture, NanoSpecialties, LLC, creates new products with nano-features for industrial markets.
Davidson says Keystone Nano is adding “at least one” worker each at its State College and Hershey locations and has hired summer interns that may be future hires.
Source: Jeff Davidson, Keystone Nano
Writer: Chris O’Toole